Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Genzyme

Information provided by (Responsible Party):

UNC Lineberger Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00577694

First received: December 19, 2007

Last updated: August 28, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Primary Completion Date:	July 2010 (Final data collection date for primary outcome measure)